| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 114.84 | 1630 |
| Intrinsic value (DCF) | 796.66 | 11898 |
| Graham-Dodd Method | n/a | |
| Graham Formula | n/a |
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.